{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:48:03Z","timestamp":1771274883018,"version":"3.50.1"},"reference-count":64,"publisher":"Impact Journals, LLC","issue":"42","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,12,29]]},"DOI":"10.18632\/oncotarget.5471","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T23:00:30Z","timestamp":1445641230000},"page":"44254-44273","source":"Crossref","is-referenced-by-count":36,"title":["FN14 and GRP94 expression are prognostic\/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies"],"prefix":"10.18632","volume":"6","author":[{"given":"Antonio","family":"Mart\u00ednez-Aranda","sequence":"first","affiliation":[{"name":"Biological Clues of the Invasive and Metastatic Phenotype Group, Molecular Oncology Department, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Barcelona, Spain"},{"name":"Universitat Aut\u00f2noma de Barcelona (UAB), Biochemistry and Molecular Biology Department, Faculty of Biosciences, Campus Bellaterra, Edifici C, Cerdanyola del Vall\u00e9s, 08193 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Biological Clues of the Invasive and Metastatic Phenotype Group, Molecular Oncology Department, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre","family":"Guney","sequence":"additional","affiliation":[{"name":"Structural Bioinformatics Laboratory, Experimental Sciences Department, Universitat Pompeu Fabra-IMIM, Barcelona Research Park of Biomedicine, 08003 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laia","family":"Muix\u00ed","sequence":"additional","affiliation":[{"name":"Biological Clues of the Invasive and Metastatic Phenotype Group, Molecular Oncology Department, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Foj","sequence":"additional","affiliation":[{"name":"Biological Clues of the Invasive and Metastatic Phenotype Group, Molecular Oncology Department, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Barcelona, Spain"},{"name":"Universitat Aut\u00f2noma de Barcelona (UAB), Biochemistry and Molecular Biology Department, Faculty of Biosciences, Campus Bellaterra, Edifici C, Cerdanyola del Vall\u00e9s, 08193 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Baixeras","sequence":"additional","affiliation":[{"name":"Servei d'Anatomia Patol\u00f2gica, Hospital Universitari de Bellvitge, 08907 L'Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Cuadras","sequence":"additional","affiliation":[{"name":"Biomarkers and Susceptibility Unit, Institut Catal\u00e0 d'Oncologia - IDIBELL, Hospital Duran i Reynals, 08907 L'Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Moreno","sequence":"additional","affiliation":[{"name":"Biomarkers and Susceptibility Unit, Institut Catal\u00e0 d'Oncologia - IDIBELL, Hospital Duran i Reynals, 08907 L'Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ander","family":"Urruticoechea","sequence":"additional","affiliation":[{"name":"Breast Cancer Unit and Neuroncology Unit, Institut Catal\u00e0 d'Oncologia - IDIBELL, Hospital Duran i Reynals, 08907 L'Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Gil","sequence":"additional","affiliation":[{"name":"Oncology Service, Institut Catal\u00e0 d'Oncologia - IDIBELL, Hospital Duran i Reynals, 08907 L'Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baldo","family":"Oliva","sequence":"additional","affiliation":[{"name":"Structural Bioinformatics Laboratory, Experimental Sciences Department, Universitat Pompeu Fabra-IMIM, Barcelona Research Park of Biomedicine, 08003 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferran","family":"Moreno","sequence":"additional","affiliation":[{"name":"Radiation Oncology Service, Institut Catal\u00e0 d'Oncologia - IDIBELL, Hospital Duran i Reynals, 08907 L'Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Gonz\u00e1lez-Suarez","sequence":"additional","affiliation":[{"name":"Transformation and Metastasis Grup, Cancer Epigenetics and Biology Department, IDIBELL, 08907 L'Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noem\u00ed","family":"Vidal","sequence":"additional","affiliation":[{"name":"Servei d'Anatomia Patol\u00f2gica, Hospital Universitari de Bellvitge, 08907 L'Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Andreu","sequence":"additional","affiliation":[{"name":"Pathology Service, Corporaci\u00f3 Sanitaria Parc Taul\u00ed, 08208 Sabadell, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miquel A.","family":"Segu\u00ed","sequence":"additional","affiliation":[{"name":"Oncology Service, Corporaci\u00f3 Sanitaria Parc Taul\u00ed, 08208 Sabadell, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Ballester","sequence":"additional","affiliation":[{"name":"Radiation Oncology Service, Institut Catal\u00e0 d'Oncologia, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Castella","sequence":"additional","affiliation":[{"name":"Pathology Service, Institut Catal\u00e0 d'Oncologia, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angels","family":"Sierra","sequence":"additional","affiliation":[{"name":"Biological Clues of the Invasive and Metastatic Phenotype Group, Molecular Oncology Department, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Barcelona, Spain"},{"name":"Molecular and Translational Oncology Laboratory, Biomedical Research Center CELLEX-CRBC Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer-IDIBAPS 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2015,10,19]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/cncr.22041","article-title":"Primary breast cancer phenotypes associated with propensity for central nervous system metastases","volume":"107","author":"Elledge","year":"2006","journal-title":"Cancer"},{"key":"2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1634\/theoncologist.2008-0052","article-title":"Central nervous system metastases in HER-2-overexpressing metastatic breast cancer: a treatment challenge","volume":"13","author":"Heinemann","year":"2008","journal-title":"Oncologist"},{"key":"3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00401-011-0933-9","article-title":"Brain metastases: pathobiology and emerging targeted therapies","volume":"123","author":"von Deimling","year":"2012","journal-title":"Acta Neuropathol"},{"key":"4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/CCO.0b013e3283571a1c","article-title":"Targeted therapy in brain metastasis","volume":"24","author":"Ruda","year":"2012","journal-title":"Curr. Opin. Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1158\/1078-0432.CCR-10-1564","article-title":"Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer","volume":"16","author":"Steeg","year":"2010","journal-title":"Clin Cancer Res"},{"key":"6","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1158\/0008-5472.CAN-06-3316","article-title":"Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain","volume":"67","author":"Aldape","year":"2007","journal-title":"Cancer Res"},{"key":"7","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1158\/0008-5472.CAN-08-4347","article-title":"Brain metastasis: opportunities in basic and translational research","volume":"69","author":"Mohla","year":"2009","journal-title":"Cancer Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Haffari","year":"2012","journal-title":"Nature"},{"key":"9","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Matese","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(03)13322-3","article-title":"DNA microarrays in breast cancer: the promise of personalised medicine","volume":"361","author":"Perou","year":"2003","journal-title":"Lancet"},{"key":"11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2164-7-96","article-title":"The molecular portraits of breast tumors are conserved across microarray platforms","volume":"7","author":"Ewend","year":"2006","journal-title":"BRMC Genomics"},{"key":"12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10549-011-1619-7","article-title":"Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse","volume":"132","author":"Perou","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"13","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1158\/0008-5472.CAN-07-5644","article-title":"Subtypes of breast cancer show preferential site of relapse","volume":"68","author":"Martens","year":"2008","journal-title":"Cancer Res"},{"key":"14","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/cncr.23930","article-title":"Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases","volume":"113","author":"Winer","year":"2008","journal-title":"Cancer"},{"key":"15","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","article-title":"Metastatic behavior of breast cancer subtypes","volume":"28","author":"Gelmon","year":"2010","journal-title":"J Clin Oncol"},{"key":"16","doi-asserted-by":"crossref","first-page":"16489","DOI":"10.3390\/ijms131216489","article-title":"An Institutional retrospective analysis of 93 patients with brain metastases from breast cancer: treatment outcomes, diagnosis-specific prognostic factors","volume":"13","author":"No\u00ebl","year":"2012","journal-title":"Int J Mol Sci"},{"key":"17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrc3053","article-title":"Brain metastases as preventive and therapeutic targets","volume":"11","author":"Smith","year":"2011","journal-title":"Nature Rev Cancer"},{"key":"18","first-page":"273","article-title":"Molecular determinants of lung cancer metastasis to the central nervous system","volume":"2","author":"Tran","year":"2013","journal-title":"Transl. Lung Cancer Res"},{"key":"19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm1469","article-title":"Tumor metastasis: mechanistic insights and clinical challenges","volume":"12","author":"Steeg","year":"2006","journal-title":"Nat Med"},{"key":"20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/A:1011132609055","article-title":"High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel","volume":"12","author":"Goldhirsch","year":"2001","journal-title":"Ann Oncol"},{"key":"21","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System","volume":"22","author":"Sawaya","year":"2004","journal-title":"J Clin Oncol"},{"key":"22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1634\/theoncologist.2011-0212","article-title":"Correlation between quantitative HER-2 protein expression and risk for brain metastases in HER-2+ advanced breast cancer patients receiving trastuzumab-containing therapy","volume":"17","author":"Foszczynska-K\u0142oda","year":"2012","journal-title":"Oncologist"},{"key":"23","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1021\/pr070426d","article-title":"Biological pathways contributing to organ-specific phenotype of brain metastatic cells","volume":"7","author":"Sierra","year":"2008","journal-title":"J Proteome Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ajpath.2011.04.037","article-title":"Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumors","volume":"179","author":"Reyal","year":"2011","journal-title":"Am J Pathol"},{"key":"25","first-page":"93","article-title":"The brain microenvironment and cancer metastasis","volume":"30","author":"Kim","year":"2012","journal-title":"Mol Cells"},{"key":"26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2105-11-56","article-title":"Biana: a software framework for compiling biological interactions and analyzing networks","volume":"11","author":"Oliva","year":"2010","journal-title":"BRMC Bioinformatics"},{"key":"27","doi-asserted-by":"crossref","first-page":"e43557","DOI":"10.1371\/journal.pone.0043557","article-title":"Exploiting protein-protein interaction networks for genome-wide disease-gene prioritization","volume":"7","author":"Oliva","year":"2012","journal-title":"PLoS One"},{"key":"28","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/bioinformatics\/btu092","article-title":"GUILDify: a web server for phenotypic characterization of genes through biological data integration and network-based prioritization algorithms","volume":"30","author":"Oliva","year":"2014","journal-title":"Bioinformatics"},{"key":"29","doi-asserted-by":"crossref","first-page":"D1035","DOI":"10.1093\/nar\/gkq1126","article-title":"DrugBank 3.0: a comprehensive resource for \u2018omics\u2019 research on drugs","volume":"39","author":"Guo","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"30","doi-asserted-by":"crossref","first-page":"8306","DOI":"10.3390\/ijms14048306","article-title":"Development of a preclinical therapeutic model of human brain metastasis with chemoradiotherapy","volume":"14","author":"Sierra","year":"2013","journal-title":"Int J Mol Sci"},{"key":"31","first-page":"1","article-title":"Intracranial implantation with subsequent 3Dbioluminescent imaging of murine gliomas","volume":"57","author":"Scheck","year":"2011","journal-title":"J Vis Exp"},{"key":"32","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ijc.2910440524","article-title":"Unique patterns of brain metastasis produced by different human carcinomas in athymic nude mice","volume":"44","author":"Fidler","year":"1989","journal-title":"Int. J. Cancer"},{"key":"33","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/j.biomaterials.2007.02.011","article-title":"Analysis of progenitor cell-scaffold combinations bynon-invasive photonic imaging","volume":"28","author":"Blanco","year":"2007","journal-title":"Biomaterials"},{"key":"34","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1158\/0008-5472.CAN-09-1528","article-title":"MDA-MB-435 and M14 cell lines: identical but not M14 melanoma?","volume":"69","author":"Chambers","year":"2009","journal-title":"Cancer Res"},{"key":"35","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/cncr.25771","article-title":"Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study","volume":"117","author":"Ardizzoni","year":"2011","journal-title":"Cancer"},{"key":"36","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1200\/JCO.2011.36.1873","article-title":"Breast cancer tumor size, nodal status, and prognosis: biology trumps anatomy","volume":"29","author":"Massagu\u00e9","year":"2011","journal-title":"J Clin Oncol"},{"key":"37","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1200\/JCO.2007.12.3588","article-title":"Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer","volume":"26","author":"Burstein","year":"2008","journal-title":"J Clin Oncol"},{"key":"38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1748-717X-8-12","article-title":"Population-based outcomes after brain radiotherapy in patients with brain metastases from breast cancer in the Pre-Trastuzumab and Trastuzumab eras","volume":"8","author":"Tyldesley","year":"2013","journal-title":"Radiat Oncol"},{"key":"39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nrclinonc.2010.170","article-title":"Breast cancer assessment tools and optimizing adjuvant therapy","volume":"7","author":"Di Leo","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"40","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1158\/0008-5472.CAN-08-0436","article-title":"A six-gene signature predicting breast cancer lung metastasis","volume":"68","author":"Bi\u00e8che","year":"2008","journal-title":"Cancer Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1039\/c2mb25104c","article-title":"A taxonomy of organ-specific breast cancer metastases based on a protein-protein interaction network","volume":"8","author":"Sierra","year":"2012","journal-title":"Mol Biosyst"},{"key":"42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrd2488","article-title":"The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting","volume":"7","author":"Winkles","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"43","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-5728(02)00368-5","article-title":"TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity","volume":"133","author":"Boucraut","year":"2002","journal-title":"J. Neuroimmunol"},{"key":"44","first-page":"1","article-title":"TWEAK and FN14 in the neurovascular unit","volume":"4","author":"Yepes","year":"2013","journal-title":"Frontier Immunol"},{"key":"45","first-page":"1","article-title":"Lenalidomide-based immunochemotherapy","volume":"2","author":"Galluzzi","year":"2013","journal-title":"OncoImmunol"},{"key":"46","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1158\/1078-0432.CCR-09-0152","article-title":"CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy","volume":"15","author":"Tao","year":"2009","journal-title":"Clin Cancer Res"},{"key":"47","doi-asserted-by":"crossref","first-page":"e89389","DOI":"10.1371\/journal.pone.0089389","article-title":"Effect of Age and Biological Subtype on the Risk and Timing of Brain Metastasis in Breast Cancer Patients","volume":"9","author":"Tzeng","year":"2014","journal-title":"PLoS One"},{"key":"48","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/bjc.2011.597","article-title":"Brain metastases free survival differs between breast cancer subtypes","volume":"106","author":"Gnant","year":"2012","journal-title":"Br J Cancer"},{"key":"49","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1158\/1541-7786.MCR-08-0005","article-title":"The Fibroblast Growth Factor-Inducible 14 Receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity","volume":"6","author":"Cunliffe","year":"2008","journal-title":"Mol Cancer Res"},{"key":"50","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nchembio.1335","article-title":"Paralog-selective Hsp90 inhibitors define tumor-specific regulation of Her2","volume":"9","author":"Chiosis","year":"2013","journal-title":"Nat Chem Biol"},{"key":"51","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/bph.12337","article-title":"The TWEAK-Fn14 system as a potential drug target","volume":"170","author":"Wajant","year":"2013","journal-title":"Br J Pharmacol"},{"key":"52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-065X.2011.01054.x","article-title":"TWEAK\/Fn14 pathway: an immunological switch for shaping tissue responses","volume":"244","author":"Zheng","year":"2011","journal-title":"Immunol Rev"},{"key":"53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1083\/jcb.200801010","article-title":"TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha","volume":"182","author":"Vaux","year":"2008","journal-title":"J Cell Biol"},{"key":"54","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1158\/1541-7786.MCR-12-0542","article-title":"The HER2- and heregulin \u03b21 (HRG)-inducible TNFR superfamily member Fn14 promotes HRG-driven breast cancer cell migration, invasion, and MMP9 expression","volume":"11","author":"Winkles","year":"2013","journal-title":"Mol Cancer Res"},{"key":"55","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.cell.2014.01.040","article-title":"Serpins promote cancer cell survival and vascular co-option in brain metastasis","volume":"156","author":"Massagu\u00e9","year":"2014","journal-title":"Cell"},{"key":"56","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/jid.2012.402","article-title":"The TWEAK receptor Fn14 is a therapeutic target in melanoma: immunotoxins targeting Fn14 receptor for malignant melanoma treatment","volume":"133","author":"Winkles","year":"2013","journal-title":"J Invest Dermatol"},{"key":"57","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1158\/1078-0432.CCR-14-1334","article-title":"A Phase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers","volume":"21","author":"Markus Roessler","year":"2015","journal-title":"Clin Cancer Res"},{"key":"58","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/ejh.12192","article-title":"Responsiveness of cytogenetically discrete human myeloma cell lines to lenalidomide: lack of correlation with cereblon and interferon regulatory factor 4 expression levels","volume":"91","author":"Jelinek","year":"2013","journal-title":"Eur J Haematol"},{"key":"59","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1470-2045(13)70380-2","article-title":"Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial","volume":"14","author":"Cavo","year":"2013","journal-title":"Lancet Oncol"},{"key":"60","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1158\/1078-0432.CCR-06-2854","article-title":"The blood-brain barrier and cancer: transporters, treatment, and Trojan Horses","volume":"13","author":"L\u00f6scher","year":"2007","journal-title":"Clin Cancer Res"},{"key":"61","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000351692","article-title":"13th St. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (Z\u00fcrich 2013)","volume":"8","author":"Diel","year":"2013","journal-title":"Breast Care"},{"key":"62","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","article-title":"Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials","volume":"379","author":"Early Breast Cancer Trialists' Collaborative Group (EBCTCG)","year":"2012","journal-title":"Lancet"},{"key":"63","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1470-2045(12)70432-1","article-title":"Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study","volume":"14","author":"Gutierrez","year":"2013","journal-title":"Lancet Oncol"},{"key":"64","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1016\/S1470-2045(13)70311-5","article-title":"Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group. Response Assessment in Neuro-Oncology (RANO) group","volume":"14","author":"Kalkanis","year":"2013","journal-title":"Lancet Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:47:01Z","timestamp":1692114421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,19]]},"references-count":64,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2015,12,29]]}},"alternative-id":["5471","26497551"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5471","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,19]]}}}